This result was consistent with the finding of a clinical trial; when patients with liver fibrosis caused by chronic hepatitis B were treated with FZHY, FZHY improved liver function parameters, particularly an increase of albumin levels47. This evidence concerns the gene ALB and Hepatic fibrosis.